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Abstract 28 
Seven isoproteic and isolipidic semi-purified diets were formulated to assess specific 29 
nutrient deficiencies in sulphur amino acids (SAA), long-chain polyunsaturated fatty 30 
acids (n3 LC-PUFA), phospholipids (PL), phosphorus (P), minerals (Min) and vitamins 31 
(Vit). The control diet (CTRL) contained these essential nutrients in adequate amounts. 32 
Each diet was allocated to triplicate groups of juvenile gilthead sea bream fed to satiety 33 
over an 11-week feeding trial. Weight gain of n/3 LC/PUFA, P-Vit, and PL-Min-SAA 34 
groups was 50%, 60-75% and 80-85% of CTRL group, respectively. Fat retention was 35 
decreased by all nutrient deficiencies except by Min diet. Strong effects on N retention 36 
were found in n3 LC-PUFA and P fish. Combined anaemia and increased blood 37 
respiratory burst were observed in n3 LC-PUFA fish. Hypoproteinemia was found in 38 
SAA, n3 LC-PUFA, PL and Vit fish. Derangements of lipid metabolism were also a 39 
common disorder, but the lipodystrophic phenotype of P fish was different to that of 40 
other groups. Changes in plasma levels of electrolytes (calcium, phosphate), metabolites 41 
(creatinine, choline) and enzyme activities (alkaline phosphatase) were related to 42 
specific nutrient deficiencies in PL, P, Min or Vit, whereas changes in circulating levels 43 
of growth hormone and insulin-like growth factor-I primarily reflected the intensity of 44 
the nutritional stressor. Histopathological scoring of liver and intestine segments 45 
showed specific nutrient-mediated changes in lipid cell vacuolisation, inflammation of 46 
intestinal submucosa, and the distribution and number of intestinal goblet and rodlet 47 
cells. These results contribute to define the normal range of variation for selected 48 
biometric, biochemical, haematological and histochemical markers.  49 
50 
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1. Introduction 51 
Clinical haematology and basic blood biochemistry are common diagnostic tools 52 
to assess health and welfare in humans and most livestock production systems
(1,2)
. In 53 
fish, although there is experimental evidence that circulating electrolytes, metabolites 54 
and hormones highly reflect impaired growth performance, stress condition and disease 55 
outcome, the use of such analyses as diagnostic tools is poorly established in practice. 56 
This is due to the paucity of reliable information on reference values of haematology 57 
and blood biochemistry parameters in healthy and well-nourished fish. Some attempts 58 
have been made to compile available data in fish blood biochemistry and haematology
(3-
59 
6)
. However, for the majority of well-established farmed finfish, grown under different 60 
rearing conditions with diverse physiological status, validated data are lacking. Besides, 61 
important gaps on reliable clinical biomarkers are arising with the advent of new fish 62 
feeds with a maximized replacement of fish meal (FM) and fish oil (FO) by alternative 63 
feedstuffs of terrestrial or marine origin. Similarly, for the histopathological scoring of 64 
relevant target tissues (liver, intestine), there is evidence of clinical signs of liver 65 
steatosis, accumulation of intestinal lipid droplets or intestine submucosa inflammation 66 
arising from lipid-related metabolic disorders
(7,8)
, but a direct link to a specific nutrient 67 
or a group of nutrients is lacking. 68 
Therefore, there is an urgent need for reliable reference values, but also for the 69 
definition of blood and histopathological parameters that have specificity, sensitivity 70 
and diagnostic value for  nutritional deficiencies. Thus, our experimental setup with a 71 
feeding trial of semi-purified diets formulated for a given nutritional deficiency in a 72 
typically marine fish, such as gilthead sea bream, considered two major steps: i) 73 
functional validation of a set of clinical data based on body composition, organosomatic 74 
indices, and blood haematology and biochemistry for the initial assessment of nutrient 75 
deficiencies in methionine (Met), essential fatty acids (EFA) such as the n-3 long-chain 76 
polyunsaturated fatty acids, phospholipids (PL), phosphorous (P) and micronutrients 77 
(minerals, vitamins) and ii) histopathological scoring of liver and intestine sections as a 78 
complementary diagnostic tool. The studied nutrient deficiencies were chosen because 79 
they are constraining factors in practical marine fish feeds with a maximized FM/FO 80 
replacement. In parallel, current work is underway for the definition of the normal range 81 
of variation of selected biomarkers, integrating the data reported herein with our own 82 
data in the framework of the ARRAINA (Advanced Research Initiatives for Nutrition 83 
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and Aquaculture) EU project, where fish were fed through the production cycle with 84 
varying inclusion levels of FM and FO (from 40% in control diet to 7.5% in the extreme 85 
low FM/FO diet).  86 
 87 
2. Experimental methods 88 
 89 
2.1. Diets  90 
 91 
Seven isonitrogenous (51-52% of dry matter, DM) and isolipidic (14.5-15.5% of 92 
DM) diets were formulated. They were produced in a semi-industrial scale (Sparos 93 
LDA, Algarve, Portugal) (Table 1). All diets contained casein (20%), casein hydrolysate 94 
(5%), gelatin (5.8%) and soy protein concentrate (34.5%) as protein sources, and were 95 
supplemented with L-threonine (0.02%). Taurine (0.3%), betaine (0.3%) and  96 
glucosamine (0.4%) were added as attractants, and ethoxyquin (0.1%) as antioxidant in 97 
all diets. DL-Methionine was supplemented at 0.4% in all diets except the diet designed 98 
to be deficient in sulphur amino acids (SAA diet). FO was added at the 13.9% in all 99 
diets except in the fatty acid (FA) deficient diet (n-3 LC-PUFA diet), in which FO was 100 
totally replaced by a blend of vegetable oils (VO) in order to reduce the EPA 101 
(eicosapentaenoic acid) and DHA (docosapentaenoic acid) contents to trace levels 102 
(Table 2). Soy lecithin (2%) was added as the unique source of PL in all diets except in 103 
the PL deficient diet. Calcium phosphate (2.2%) was added in all diets except in the P 104 
deficient diet. Mineral premix based on available data on mineral requirements of fish
(9)
 105 
was included at 2.2% in all diets except in the diet designed to be mineral deficient (Min 106 
diet). Vitamin premix based on NRC
(10)
 was added in all diets at an incorportaion level 107 
of 2% except in the diet designed to be vitamin deficient (Vit diet).  108 
 109 
2.2. Feeding trial and fish sampling  110 
 111 
Juvenile sea bream of Atlantic origin (Ferme Marine de Douhet, Ile d’Oléron, 112 
France) were acclimatised to laboratory conditions for one month before the start of a 113 
12 weeks trial (May-July) in the indoor experimental facilities of the Institute of 114 
Aquaculture Torre de la Sal (IATS-CSIC). Following the acclimatisation period, fish of 115 
15 g initial mean body weight were randomly distributed into 500 L-tanks in triplicate 116 
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groups of 35 fish each. Fish were fed to visual satiety one (12 h)/two times (9h, 14 h) 117 
per day (6 days per week). The trial was conducted under natural photoperiod and 118 
temperature conditions at IATS latitude (40°5N; 0°10E), increasing water temperature 119 
from 19 ºC in May to 24ºC at the end of July. Water flow rate was 20 L/min, oxygen 120 
content of water effluents was always higher than 85% saturation, and unionised 121 
ammonia remained below toxic levels (<0.02 mg/L).  122 
At the end of the trial and following overnight fasting (10-12 h in the morning), 123 
18 fish per dietary treatment (six per tank) were randomly selected and decapitated 124 
under anaesthesia with 3-aminobenzoic acid ethyl ester (MS-222, 100 μg/mL). Blood 125 
was taken from caudal vessels with heparinised syringes (less than five minutes for all 126 
the  fish sampled from each tank). One aliquot was used for measurements of 127 
haematological parameters and respiratory burst activity of blood leukocytes. The 128 
remaining blood was centrifuged at 3,000 g for 20 min at 4ºC, and the resulting plasma 129 
was stored in separate aliquots at -20ºC until further assays were performed. Viscera, 130 
liver and mesenteric fat were weighed and representative portions of liver and intestine 131 
segments (anterior and posterior) were taken for histological processing. When blood 132 
and tissue collection was completed, additional fish (4 fish per tank) were taken for 133 
whole body composition analyses.  134 
The experimental protocol was approved by the Agencia Estatal Consejo Superior 135 
de Investigaciones Científicas, IATS Review Board, and all procedures were in 136 
accordance with national and current EU legislations on the handling of experimental 137 
animals.  138 
 139 
2.3. Chemical composition  140 
 141 
Diets and fish for body composition analyses (a pooled sample of 10 fish at the 142 
beginning and pools of 4 fish per tank at the end of trial) were ground, and small 143 
aliquots were dried to determine moisture content. The remaining samples were freeze-144 
dried and chemical analyses were made: dry matter by drying at 105 °C for 24 h, protein 145 
(N x 6.25) by the Kjeldahl method, and fat after dichloromethane extraction by the 146 
Soxhlet method.  147 
Total lipids for analyses of dietary FA acid composition were extracted by the 148 
method of Folch et al.
(11)
, with chloroform-methanol (2:1, v v-1) containing 0.01% 149 
butylated hydroxytoluene (BHT) as antioxidant. After the addition of nonadecanoic FA 150 
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(19:0) as internal standard, total lipids were subjected to acid-catalysed transmethylation 151 
for 16 h at 50°C using 1 mL toluene and 2 mL of 1% (v v-1) sulphuric acid in 152 
methanol
(12)
. FA methyl esters (FAME) were extracted with hexane:diethyl ether (1:1) 153 
and purified by thin layer chromatography (Silica gel G 60, 20 × 20 cm glass plates, 154 
Merck, Darmstadt, Germany), using hexane:diethyl-ether:acetic acid (85:15:1.5) as a 155 
solvent system. FAMEs were then analysed with a Fisons Instruments GC 8000 Series 156 
(Rodano, Italy) gas chromatograph as described elsewhere
(13)
. Individual FAMEs were 157 
identified by comparison with well characterised sardine oil (Marinol, Fishing Industry 158 
Research Institute, Rosebank, South Africa) and the FAME 37 mix from Supelco 159 
(Bellefonte, PA, USA). BHT and internal standards (19:0) were obtained from Sigma-160 
Aldrich (Madrid, Spain). All solvents in lipid extraction and FA analyses were HPLC 161 
grade and were obtained from Merck.  162 
 163 
2.4. Haematology 164 
 165 
Haemoglobin (Hb) concentration was determined with a HemoCue B-166 
Haemoglobin Analyser® (AB, Leo Diagnostic, Sweden), which uses a modified azide 167 
methaemoglobin reaction for Hb quantification. The haematocrit (Hct) was measured 168 
after centrifugation of the blood in heparinised capillary tubes at 13,000 g for 10 169 
minutes. Red blood cell (RBC) counts were made in a Neubauer chamber using an 170 
isotonic solution (1% NaCl). Erythrocyte osmotic fragility test was made in hypotonic 171 
NaCl solutions with haemolysis read at 540 nm. Median corpuscular fragility (MCF) 172 
was defined as the concentration of NaCl (g/L) causing 50% lysis. 173 
 174 
2.5. Blood biochemistry 175 
 176 
Plasma glucose was measured by the glucose oxidase method (ThermoFisher 177 
Scientific, Waltham, Massachusetts, USA). Plasma triglycerides (TG) were determined 178 
using lipase/glycerol kinase/glycerol-3phosphate oxidase reagent. Total plasma 179 
cholesterol was determined using cholesterol esterase/cholesterol dehydrogenase 180 
reagent (ThermoFisher Scientific). HDL and LDL/VLDL cholesterol were determined 181 
with the kit (EHDL-100) of BioAssay Systems (Hayward, California, USA), based on 182 
an improved polyethylene glycol precipitation method in which HDL and LDL/VLDL 183 
are separated, and cholesterol concentrations are determined using cholesterol 184 
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esterase/cholesterol dehydrogenase reagent. Total plasma proteins were measured with 185 
the Bio-Rad protein reagent (Hercules, California, USA) with bovine serum albumin as 186 
standard.  187 
Changes in plasma enzyme activities of alanine aminotransferase (ALAT, EC 188 
2.6.1.2) (EALT-100), aspartate aminotransferase (ASAT, EC 2.6.1.1) (EASTR-100) 189 
and glutamate dehydrogenase (GLDH, EC 1.4.1.2) (DGLDH-100) were measured using 190 
colorimetric assay kits (BioAssays Systems). Plasma alkaline phosphatase (ALP, EC. 191 
3.1.3.1) activity was determined by a fluorimetric assay kit (QFAP-100, BioAssays 192 
Systems). 193 
Plasma levels of creatinine (DICT-500), choline (ECHO-100), calcium (DICA-194 
500), chloride (DICL-250), magnesium (DMG-250) and phosphate (DIPI-500) were 195 
measured by colorimetric assay kits (BioAssays Systems). Total antioxidant capacity 196 
was measured as Trolox activity using a microplate assay kit (709001) (Cayman 197 
Chemical, Ann Arbor, Michigan, USA). Plasma lysozyme activity was measured by a 198 
turbidimetric assay
(14)
 adapted to microplates, as previously described
(15)
. Induction of 199 
the respiratory burst (RB) activity in blood leukocytes was measured directly from 200 
heparinised blood, following the method described by Nikoskelainen et al.
(16)
 with some 201 
modifications
(17)
.  202 
Plasma GH was determined by a homologous gilthead sea bream 203 
radioimmunoassay (RIA) as reported elsewhere
(18)
. The sensitivity and midrange 204 
(ED50) of the assay were 0.15 and 1.8 ng/mL, respectively. Plasma IGFs were extracted 205 
by acid-ethanol cryoprecipitation
(19)
, and the concentration of IGF-I was measured by 206 
means of a generic fish IGF-I RIA validated for Mediterranean perciform fish
(20)
. The 207 
sensitivity and midrange of the assay were 0.05 and 0.7–0.8 ng/mL, respectively. 208 
 209 
2.6. Histology  210 
 211 
For histological examination, pieces of liver, anterior (a piece inmediately after the 212 
piloric caeca) and posterior (a piece immediately before the rectum) intestinal segments 213 
were fixed in 10% buffered formalin, embedded in paraffin, 4 µm-sectioned and stained 214 
with Giemsa and periodic acid-Schiff (PAS). Histochemical reactivity in tissues was 215 
evaluated by grading staining using the following scale: negative (−), slight (+), 216 
moderate (++), and marked (+++). 217 
 218 
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2.7. Statistical analysis 219 
 220 
Data on growth performance and blood haematology and biochemistry were 221 
analysed by one-way ANOVA followed by Student Newman-Keuls (SNK) test (P < 222 
0.05). All analyses were performed with the SPSS 17.0 program (SPSS, Inc. Chicago, 223 
IL, USA). 224 
 225 
3. Results 226 
  227 
3.1. Growth performance  228 
 229 
Data on growth, somatic indexes and body composition are shown in Table 3. As 230 
a general rule, nutrient deficient diets reduced significantly feed intake, growth rates and 231 
feed efficiency in fish fed P and n-3 LC-PUFA diets. This resulted in a weight gain of 232 
50% (n/3 LC/PUFA), 60-75% (P, Vit) and 80-85% (PL, Min, SAA) of CTRL fish. 233 
Mesenteric fat index (MSI) was markedly reduced in Vit fish. The same was 234 
observed in PL and n-3 LC-PUFA groups, although there were no statistically 235 
significant differences. Conversely, MSI was significantly increased in P fish. 236 
Hepatosomatic index (HIS) was also altered by dietary treatments, and it was largely 237 
increased in n-3 LC-PUFA fish. The opposite was found in Min fish and in a lower 238 
extent in Met and Vit fish. 239 
Dietary treatment also altered whole body composition with a low protein and 240 
lipid content in fish fed P and Vit diets, respectively. This feature was related to a strong 241 
decrease in N retention in P and n-3 LC-PUFA fish. Lipid retention was significantly 242 
reduced by nutrient deficiencies in all experimental groups with the exception of Min 243 
fish.  244 
 245 
3.2. Blood analyses 246 
 247 
Data on blood analysis are shown in Table 4. Hb concentration, Hct and RBC 248 
counts were significantly lower in n-3 LC-PUFA fish than in CTRL fish. This feature 249 
was related to a greater osmotic fragility, evidenced by the significant increase of MCF 250 
values from 6.6 g/L in CTRL fish to 7.4 g/L in n-3 LC-PUFA fish. Other experimental 251 
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groups did not show any statistically significant alteration of haematological 252 
parameters. 253 
Blood biochemistry was altered in a nutrient specific manner, and a strong 254 
hypotriglyceridemia, hypocholesterolemia and hypoproteinemia with decreased plasma 255 
levels of creatinine were found in n-3 LC-PUFA fish, but also in Vit fish. 256 
Hypoproteinemia was a sign of SAA and PL deficiency, whereas hypertriglyceridemia 257 
and hypercholesterolemia were characteristic features of P fish. Low plasma choline 258 
levels were found in SAA, Min and Vit fish. 259 
Plasma electrolytes were highly refractory to dietary treatment in our 260 
experimental conditions with the exception of calcium and phosphate in fish fed diets 261 
non-supplemented with the vitamin premix and inorganic P, respectively. Likewise, 262 
enzyme activities of ALAT, ASAT and GLGH were not modified by dietary treatment, 263 
whereas ALP activity was significantly decreased in PL fish but increased in P and Min 264 
fish groups. Lysozyme activity was not altered by any dietary treatment. By contrast, 265 
RB was triggered in a consistent manner in n-3 LC-PUFA fish. Plasma antioxidant 266 
capacity was also increased by nutrient deficiencies, although this feature was especially 267 
evident in fish fed P, Min and Vit diets. 268 
Regarding growth factors, circulating levels of GH highly reflected the 269 
impairment of growth performance and the highest plasma concentration was observed 270 
in n-3 LC-PUFA fish, followed by fish fed P and Vit diets. The opposite was found for 271 
circulating levels of IGF-I and the lowest IGF-I concentration was found in n-3 LC-272 
PUFA and P fish groups. 273 
 274 
3.3. Histopathological traits 275 
 276 
The histological examination of liver and intestine showed different features, 277 
which are summarised in Table 5. Representative differential microphotographs are also 278 
provided in Figures 1 to 3. The highest level of fat accumulation either in the liver or 279 
anterior intestine was observed in fish fed n-3 LC-PUFA, but without reaching steatosis. 280 
Accumulation of glycogen in the liver (revealed by PAS staining) was observed in fish 281 
fed SAA, P and Vit diets, but it was not extreme. No fat accumulation was observed in 282 
the posterior intestine in any of the groups. Goblet cell content and number varied with 283 
the diet, a clear decrease in the number of neutral mucins (stained with PAS) was 284 
observed at anterior intestine of fish fed n-3 LC-PUFA, PL, P and Min diets. In all fish 285 
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groups the number of PAS+ goblet cells was lower at posterior intestine than at anterior 286 
intestine, and only PL and Vit fish had slight staining. The number of Giemsa-stained 287 
goblet cells was also decreased in P, Min and Vit fish. The staining of the epithelial 288 
layer of the posterior intestine was biphasic in the samples from all the experimental 289 
diets, except SAA and PL, in which it was homogenous as in CTRL ones. The number 290 
of granulocytes in the submucosae at anterior intestine and posterior intestine was not 291 
outstanding, except in Vit at anterior intestine. Vit was the only diet in which 292 
intraepithelial lymphocytes were in higher number than in the CTRL diets in both 293 
intestinal segments. It was also remarkable the high number of rodlet cells in the 294 
posterior intestine epithelium of PL, P, Min and Vit fish, with the highest level in Min 295 
fish.  296 
 297 
4. Discussion 298 
 299 
Comprehensive approaches have been used to address the total or partial FM/FO 300 
replacement in a wide range of finfish, including rainbow trout
(21)
 and typically marine 301 
fish, such as European sea bass
(22)
 and gilthead sea bream. In particular, for gilthead sea 302 
bream, the long-term consequences of feeding low FM/FO feeds on growth 303 
performance and endocrine status
(7,23,24)
, health and welfare 
(17,25-30)
, fish quality
(13,31,32)
 304 
and food safety
(33,34)
 have been considered in a highly integrated manner. However, 305 
knowledge on the specific effects and consequences of a given nutrient or a group of 306 
nutrients is mostly lacking. Thus, this is one of the first studies analysing at the same 307 
time the effects of dietary deletion or reduction of six different nutrients recognised as 308 
essential to fish
(10)
, which contributes to fill the gaps in the diagnosis of the nutritional 309 
fish condition under standardised rearing conditions. Of note, we did not have the same 310 
degree of deficiency for the six different nutrients tested. Indeed, EPA and DHA 311 
contents were reduced to trace levels in the n-3 LC-PUFA diet with the total 312 
replacement of FO by VO. Likewise, the main source of P in CTRL diet was the added 313 
calcium phosphate, but more difficult was to induce a severe Met deficiency preserving 314 
the supply of other essential amino acids. 315 
Adipose tissue (AT) is now recognised as an important target tissue for the 316 
diagnosis and treatment of most lipid metabolic disorders arising from an excessive 317 
lipid influx
(35)
. Clinically, lipotoxicity not only appears with fattening, but also with 318 
hypoxia, blockage of glucocorticoid sensitive pathways, and the acquisition and 319 
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maintenance of inflammatory phenotypes
(36-38)
. In humans as well as in other animal 320 
models, FO and n-3 LC-PUFA of FO are able to reverse these clinical symptoms, 321 
decreasing lipolysis and alleviating the inflammatory condition of AT, which, in turn, 322 
reduces the production of lipolytic cytokines, the release of free FA and thereby the risk 323 
of hepatic steatosis
(39)
. This liver syndrome is the result of a massive synthesis and/or 324 
deposition of TG in the form of lipid vacuoles, and it is commonly observed in many 325 
fish species challenged with xenobiotics and unbalanced diets
(40)
. This metabolic 326 
derangement is often accompanied by the displacement of the nucleus of hepatocytes 327 
and even pyknosis. Relatively little is known on the ultimate mechanism, although  the 328 
dietary protein source and protein/energy ratio have a major effect on the regulation of 329 
lipid metabolism in European sea bass
(41,42)
. The replacement of FM and FO with plant 330 
protein and oil sources also has a number of effects on the regulation of intermediary 331 
metabolism in trout
(43)
 and Atlantic salmon
(44)
. In gilthead sea bream, tissue FA 332 
uptake
(45,46)
 and mitochondrial respiration uncoupling
(47)
 are highly affected by FM and 333 
FO replacement with plant ingredients. In addition, increases in cell size and lipolytic 334 
rates are characteristic features of isolated adipocytes from fish fed either plant proteins 335 
or VO
(48,49)
, and lipoid liver degeneration is frequently observed as a metabolic 336 
disturbance in gilthead sea bream fed high plant ingredient-based feeds
(7,23,50)
. 337 
Accordingly, the present study shows that the total replacement of FO by VO in FM-338 
free diets (n-3 LC-PUFA diet) caused a slight reduction of MSI related to a 339 
lipodystrophic phenotype with clinical signs of hypolipidemia and hepatomegaly (high 340 
HSI). The loss of mesenteric AT mass, together with low plasma levels of choline and 341 
calcium, was even higher in the reduce vitamin supply. However, abnormal liver lipid 342 
deposition rates was not found by light microscopy in this group of fish. Therefore, the 343 
absence or modification of AT mass cannot be used as the only criterion for the risk 344 
assessment of liver steatosis.  345 
The main signs of P deficiency in fish nutritional studies are poor bone 346 
mineralisation and bad growth performance
(9,51)
, which were correlated in the present 347 
study with low plasma phosphate concentrations and high plasma activities of ALP in 348 
the absence of apparent skeletal deformities. ALP activity is a well-known bone 349 
turnover biomarker 
(52)
, but herein we also observed an increased plasma ALP activity 350 
with the reduced dietary supply of trace minerals (iron, magnesium, zinc, copper and 351 
selenium) in Min fish. However, the increase in MSI in combination with hyperlipemia 352 
allows differentiating the effects of deficiency in P from those due to deficiencies in 353 
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trace minerals. In this sense, it must be noted than an important role of P in the 354 
regulation of lipid metabolism has also been reported in other fish species
(53,54)
. 355 
Hct and Hb values are general indicators of health, and these haematological 356 
parameters change in response to nutrient deficiencies, environmental conditions, 357 
growth status and anti-nutritional factors
(55,56)
. A high incidence of anaemia has been 358 
reported in yellowtail and parrot fish fed FM-free diets
(57,58)
. This has been attributed, at 359 
least in part, to taurine deficiency, and thus its supplementation seems to be required 360 
when these fish are fed low levels of taurine in FM or plant protein-based diets
(59)
. In 361 
our study, all the diets were supplemented with taurine (0.3%), and anaemia signs, such 362 
as low RBC, Hct and Hb values were found only in fish fed the n-3 LC-PUFA diet, 363 
which also showed an increased erythrocyte osmotic fragility, as reported in rats with 364 
deficiencies in LC-PUFA
(60)
. Importantly, this clinical sign was not found in the PL fish 365 
group, and therefore contributes to better define the sometimes-overlapping signs of 366 
nutrient deficiencies in EFA and PL.  367 
Previous studies in gilthead sea bream have already highlighted increased RB of 368 
blood leukocytes in fish fed diets with a high replacement of FO by VO
(17,25)
. This is 369 
confirmed herein and importantly RB turned out to be a specific criterion for the 370 
diagnosis of n-3 LC-PUFA deficiency, as it was notably increased in this group and not 371 
with PL or other nutrient-induced deficiencies. Likewise, a close talk between PL and 372 
bone metabolism exists and the decrease in plasma ALP activity is becoming an easy 373 
and highly valuable marker of PL deficiencies in gilthead sea bream. Of note, a high PL 374 
supply is required during early life fish stages to improve survival rates and to decrease 375 
the incidence of skeletal deformities
(61)
, but PL requirements in juvenile and adult fish 376 
are still controversial
(62,63)
. 377 
Plasma transaminases and GLDH are commonly used in clinical chemistry as 378 
markers of tissue damage
(64)
, but the current results indicate that they are poorly 379 
informative of nutritionally-mediated metabolic derangements in gilthead sea bream. By 380 
contrast, overall plasma total antioxidant activity was increased in parallel to the 381 
reduced growth performance, indicative of a reduced aerobic metabolism and, therefore, 382 
of a reduced production of reactive oxygen species (ROS). Strong support for this 383 
comes from inbreeding selection of rat strains, which demonstrates that most stressful 384 
and oxidative risk factors correlate with the low expression of genes required for 385 
mitochondrial biogenesis and oxidative phosphorylation
(65)
. Experimental evidence also 386 
indicates that plasma antioxidant capacity is increased by hypoxia exposure, probably 387 
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due to the concurrent decrease of basal metabolism, mitochondrial respiration 388 
uncoupling and oxidative phosphorylation
(66)
. However, the magnitude and even the 389 
direction of the change is poorly predictable when comparisons are made between this 390 
and previous feeding trials with practical diets containing FM
(17)
.  391 
Most growth regulatory events of fish are mediated at hormonal level by the 392 
GH/IGF axis, keeping pituitary GH secretion and hepatic/extra-hepatic IGF production 393 
under control
(67-69)
. Hence, circulating GH and IGF-I are one of the most important 394 
endocrine determinants of growth in a vast array of stress and nutritional disorders 395 
arising from crowding and handling stress
(70)
, changes in ration size
(68,71)
, dietary 396 
protein/energy ratio
(72,73)
 and dietary protein and lipid sources
(23,24,74)
. This notion is also 397 
found herein, and importantly a close positive correlation between growth rates and 398 
circulating levels of IGF-I was evidenced regardless of the nutrient deficiency. As 399 
expected, an opposite trend was found for GH and growth rates, which would reflect a 400 
lowered negative feedback inhibition of IGFs upon pituitary GH release as a result of a 401 
transcriptional defect in the signal transduction of GH receptors. This metabolic feature 402 
leads to liver GH resistance and reduced hepatic IGF production in spite of increased 403 
plasma levels of GH, as it has been early stated in a wide range of fish species, 404 
including gilthead sea bream
(71,75-77)
.  405 
Histological traits also gave interesting information on the possible pathological 406 
outcome of nutrient deficiencies. The highest accumulation of hepatic lipids was found 407 
in gilthead sea bream fed the n-3 LC-PUFA deficient diet, followed by SAA, P and 408 
Min. However, lipid accumulation did not reach the highest score of steatosis observed 409 
by us with other dietary interventions
(7,15)
, or by other authors using diets with an excess 410 
of dietary lipids
(78)
, EFA deficiencies
(79)
 and VO
(50,80,81)
. Glycogen accumulation was 411 
also high in the liver of SAA, P and Vit fish, although the observed glycogen deposition 412 
did not reach an extreme condition. Massive accumulation of supranuclear lipid droplets 413 
at the intestinal epithelial layer is also considered a sign of inadequate/unbalanced diets 414 
due to a reduced metabolisation of absorbed lipids, either because they are not needed 415 
or because they are absorbed in a higher amount than needed. This accumulation was 416 
not observed at the posterior intestine for any diet, but it was a clear feature at the 417 
anterior intestine after feeding with n-3 LC-PUFA, PL and Vit deficient diets. This 418 
epithelial accumulation stands as an earlier marker of deregulated lipid metabolism 419 
compared to lipid accumulation in the liver, as it was visible in PL and Vit fed fish, in 420 
which lipoid liver degeneration was not found. 421 
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Another histological feature with clear differences among fish was the number 422 
of goblet cells and their staining characteristics. In this sense, it is noteworthy that the 423 
n3 LC-PUFA diet induced a strong reduction in the number of goblet cells, and the 424 
remaining goblet cells were not stained either by Giemsa or PAS, indicating that mucin 425 
content was not neutral or acidic. Neutral mucins were also absent at anterior intestine 426 
as a result of the feeding with all the diets except SAA and Vit, and at posterior intestine 427 
except PL and Vit. Previous gilthead sea bream studies indicate that other models of 428 
nutritional- and parasite-induced enteritis also invoke modifications in goblet cells type 429 
and number
(26,82)
. In fact, the 66% replacement of FO by VO in plant protein-based diets 430 
produced a significant decrease in GC with neutral and acidic mucins at anterior 431 
intestine and medium intestine and also in those with carboxylic mucins and sialic acid 432 
at medium intestine, but no significant changes at posterior intestine. In European sea 433 
bass fed with mannan oligosaccharides, the number of goblet cells secreting acidic 434 
mucins was increased
(83)
. In yellow perch fed with wheat-gluten-protein-based diets 435 
even supplemented with free lysine, the number of goblet cells was also decreased
(84)
. 436 
By contrast, Atlantic salmon
(85)
, Atlantic cod
(86)
 and carp
(87)
 fed high-plant-protein-437 
based diets presented goblet cells hypertrophy and hyperplasia.  438 
Rodlet cells are exclusive of teleost epithelial layers and represent a cell type 439 
whose function has not definitively been established, although considered to be closely 440 
linked to the immune system and osmoregulation
(88)
. Many studies consistently report 441 
an association between rodlet cells proliferation/ hyperplasia and the presence of a 442 
variety of parasites, chemicals and environmental stressors
(89,90)
 and they even have 443 
been proposed as biomarkers
(89)
. However, there is no previous report on the 444 
relationship with the diet. In the current study, the number of rodlet cells was increased 445 
only at posterior intestine, notably in fish fed Min diet. The increased presence of 446 
Rodlet cells could therefore be interpreted either as a sign of inflammation or 447 
osmoregulatory imbalance and reinforce the idea that cell osmoregulation is dependent 448 
on trace minerals rather than P uptake. The higher presence of rodlet cells was 449 
coincident with other inflammatory markers (intraepithelial lymphocytes and 450 
submucosal granulocytes) in fish feed Min, PL and Vit diets either at anterior intestine 451 
or posterior intestine. In any case, the observed cellular inflammation was mild and by 452 
no means comparable with that caused by other dietary interventions in Atlantic 453 
salmon
(91)
, common carp
(87)
 or gilthead sea bream
(15)
.  454 
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In summary, clinical blood biochemistry and tissue histopathology have been 455 
proved highly informative to assess nutritional condition of farmed gilthead sea bream. 456 
The final diagnosis outcome might require confirmation by more specific assays, but the 457 
generated information is by itself useful for the overall assessment of fish performance 458 
and metabolic condition when the measured parameters are referred to a control group 459 
or historical data for a given fish strain, life stage and/or rearing condition. All this 460 
information is summarised in Supplemental Table 1 as a set of clinical signs for a given 461 
nutritional deficiency in gilthead sea bream. To establish the normal range of variation 462 
of these parameters as a function of season and growth performance, the data from this 463 
study were combined with those derived from other past and on-going feeding trials 464 
with practical diets. The rationale for this is to cover a wide range of variation for 465 
marine and plant ingredients without apparent detrimental effects on fish performance 466 
through the production cycle. The reference values for these studied biomarkers are 467 
shown in Supplemental Table 2, and will be periodically updated on the basis of the 468 
data produced within the ARRAINA project. 469 
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Figure legends 488 
 489 
Figure 1. Histochemical staining of liver sections from gilthead sea bream fed the 490 
control diet (A, B), the CL-PUFA diet (C, D) or the SAA diet (E, F). Stainings: Giemsa 491 
(A, C, E), PAS (B, D, F). Scale bars = 20 µm. 492 
 493 
Figure 2. Histochemical staining of anterior intestine sections from gilthead sea bream 494 
fed the control diet (A, B), the CL-PUFA diet (C, D) or the Vit (E, F). Stainings: 495 
Giemsa (A, C, E), PAS (B, D, F). Scale bars = 20 µm. 496 
 497 
Figure 3. Histochemical staining of posterior intestine sections from gilthead sea bream 498 
fed the control diet (A, B), the CL-PUFA diet (C, D) or the Min (E, F). Stainings: 499 
Giemsa (A, C, E), PAS (b, d, f). Scale bars = 20 µm. Inset in C shows detail of rodlet 500 
cells in the epithelium; inset in E shows the abundant granulocytes in the submucosa. 501 
 502 
 503 
 504 
  505 
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Table 1. Ingredients and chemical composition of experimental diets. 781 
1
Supplied the following (g/kg mix): calcium hydrogen phosphate 500, calcium carbonate 782 
(40% Ca) 215, sodium chloride 40, ferrous sulphate (21% Fe) 20, manganese sulphate 3, 783 
zinc sulphate 4, copper sulphate 3, cobalt (II) chloride (25% Co) 0.02, potassium iodine 784 
0.04, sodium selenite 0.03, sodium fluoride 1, magnesium hydroxide (60% Mg) 124, 785 
potassium chloride 90. 786 
2
Supplied the following (g/kg mix, except as noted): retinyl acetate 1, DL-cholecalciferol 787 
2.5, DL-α tocopheryl acetate 5, menadione sodium bisulphite 1, ascorbic acid 20, thiamin 788 
0.1, riboflavin 0.4, pyridoxine 0.3, vitamin B12 10 mg, nicotinic acid 1, pantothenic acid 789 
2, folic acid 0.1, biotin 10 mg, choline chloride 200, inositol 30.  790 
    Diet    
 CTRL SAA 
n-3 
LC-PUFA 
PL P Min Vit 
Ingredient (%)        
Casein 20 20 20 20 20 20 20 
Casein hydrolisate 5 5 5 5 5 5 5 
Gelatin 5.78 5.78 5.78 5.78 5.78 5.78 5.78 
Soy protein concentrate 
(Soycomil PC) 
34.5 34.5 34.5 34.5 34.5 34.5 34.5 
DL-Methionine 0.4 0 0.4 0.4 0.4 0.4 0.4 
L-Threonine 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
Dextrine 11.2 11.2 11.2 11.2 11.2 11.2 11.2 
Soy lecithin 2 2 2 0 2 2 2 
Fish oil 13.9 13.9 0 13.9 13.9 13.9 13.9 
Vegetable oil  0 0 13.9 0 0 0 0 
Cellulose 0 0.4 0 0 2.2 1.5 1.5 
CaHPO4.2H2O (18%P) 2.2 2.2 2.2 2.2 0 2.2 2.2 
Mineral premix-INRA
1
 2 2 2 2 2 0.5 2 
Vitamin premix-INRA
2
 2 2 2 2 2 2 0.5 
Taurine 0.3 0.3 0.3 0.3 0.3 0.3 0.3 
Betaine 0.3 0.3 0.3 0.3 0.3 0.3 0.3 
Glucosamine 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
Ethoxyquin (75%) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
       
Proximate composition       
Dry matter (DM, %) 92.4 92.5 95.4 93.3 95.5 92.2 92.8 
Crude protein (% DM) 51.8 51.5 50.8 51.1 50.8 52.0 52.5 
Crude fat (% DM) 15.0 15.1 15.5 15.6 14.4 14.7 14.7 
EPA+DHA (% DM) 2.68 2.68 0.03 2.83 2.60 2.64 2.37 
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Table 2. Fatty acid composition of experimental diets (% total FAME). 791 
Values are means of two determinations; tr = trace value < 0.05. 792 
1 
Fatty acids with at least 20 carbon atoms and more than 3 double bonds.793 
    Diet    
Fatty acid  CTRL SAA 
n-3 
LC-PUFA 
PL P Min Vit 
14:0  6.81 7.06 0.51 7.38 7.03 7.06 7.50 
15:0 0.61 0.74 0.24 0.79 0.76 0.68 1.01 
16:0 17.56 18.11 15.48 18.53 18.58 18.47 19.13 
16:1n-7  7.36 7.44 0.24 7.60 7.29 7.31 7.46 
16:2 0.91 0.92 0.12 1.06 1.02 1.23 1.13 
16:3 1.25 1.25 0.06 1.29 1.20 1.26 1.21 
16:4 1.37 1.37 0.08 1.41 1.31 1.36 1.30 
17:0 0.48 0.49 tr 0.52 0.51 0.51 0.53 
18:0 3.36 3.47 4.68 3.48 3.62 3.56 3.69 
18:1n-9  10.87 10.79 30.57 10.68 10.84 10.76 10.95 
18:1n-7  2.49 2.52 0.98 2.57 2.52 2.52 2.57 
18:2n-6  3.98 3.87 16.46 2.09 3.81 3.81 3.66 
18:3n-3  1.10 1.07 27.44 1.10 1.13 1.09 1.01 
18:3n-6  0.30 0.30 0.09 0.31 0.29 0.30 0.29 
18:4n-3 2.21 2.22 tr 2.26 2.14 2.23 2.07 
20:0 0.29 0.28 0.32 0.29 0.30 0.29 0.33 
20:1n-9  2.32 0.81 0.38 2.51 2.46 2.43 2.48 
20:1n-7  0.21 0.21 tr 0.22 0.21 0.21 0.22 
20:2n-6  0.15 0.15 0.07 0.15 0.15 0.15 0.15 
20:3n-3  0.07 0.07 tr 0.07 0.07 0.07 0.06 
20:3n-6 0.07 0.05 tr 0.05 0.05 0.05 0.06 
20:4n-6  0.90 0.91 tr 0.92 0.88 0.91 0.85 
20:4n-3  0.61 0.61 tr 0.62 0.60 0.61 0.58 
20:5n-3 (EPA)  12.98 13.01 0.18 13.17 12.56 13.06 11.88 
21:0 0.08 0.10 tr 0.08 0.09 0.09 0.08 
21:5n-3 0.48 0.49 tr 0.49 0.47 0.49 0.44 
22:0 0.12 0.13 0.19 0.11 0.13 0.13 0.14 
22:1n-11  3.34 3.58 tr 3.66 3.69 3.61 3.61 
22:1n-9  0.20 0.11 0.05 0.11 0.08 0.11 0.10 
22:4n-6  0.08 0.08 tr 0.08 0.08 0.09 0.08 
22:5n-3  1.39 1.40 0.10 1.41 1.36 1.40 1.27 
22:6n-3 (DHA)  9.94 9.95 0.07 10.05 9.60 9.98 8.96 
Total  94.14 93.81 98.37 95.28 95.10 95.00 96.08 
Saturates  29.31 30.38 21.44 31.19 31.03 30.79 32.40 
Monoenes  26.79 25.48 32.26 27.34 27.09 26.96 27.39 
n-6 LC-PUFA
 1
  0.98 0.99 tr 1.00 0.95 0.99 0.93 
n-3 LC-PUFA
1
  25.41 25.45 0.38 25.73 24.59 25.55 23.13 
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Table 3. Effect of nutrient deficiencies on growth performance of gilthead sea bream fed to visual satiety from May to July (13 weeks). Data 794 
on body weight, feed intake, growth indices and body composition are the mean (SEM) of triplicate tanks. Data on viscera, mesenteric fat and 795 
liver weight are the mean (SEM) of 20 fish. Different superscript letters in each row indicate significant differences among dietary treatments 796 
(SNK test, P<0.05). 797 
1
Result values from one-way analysis of variance; 
2
Viscerosomatix index = (100 x viscera weight) / fish weight 798 
3
Mesenteric index = (100 x mesenteric fat weight) / fish weight; 
4
Hepatosomatic index = (100 x liver weight) / fish weight 799 
5
Specific growth rate = 100 x (ln final body weight - ln initial body weight) / days; 
6
Feed Efficiency = wet weight gain / dry feed intake  800 
    Diet     
 CTRL SAA 
n-3 
LC-PUFA 
PL P Min Vit P-value
1
 
Initial body weight (g) 15.1(0.06) 15.1(0.21) 15.2(0.14) 15.0(0.25) 15.1(0.11) 15.0(0.04) 15.2(0.08) 0.977 
Final body weight (g) 85.5(1.58)
a
 72.5(1.41)
b
 51.2(0.17)
d
 71.7(1.80)
b
 60.2(0.66)
c
 71.5(2.12)
b
 66.1(0.65)
bc
 <0.001 
Feed intake (g DM/fish) 65.9(1.46)
a
 54.7(1.36)
b
 37.9(0.68)
d
 49.6(2.16)
bc
 51.4(0.91)
bc
 51.6(1.73)
bc
 46.9(0.59)
c
 <0.001 
Viscera (g) 6.39(0.27)
a
 5.34(0.23)
b
 4.40(0.21)
d
 5.80(0.19)
ab
 5.79(0.18)
b
 5.54(0.20)
abc
 4.90(0.16)
cd
 <0.001 
Mesenteric fat (g) 1.14(0.13)
a
 0.92(0.12)
abc
 0.58(0.09)
c
 0.79(0.08)
bc
 1.27(0.11)
a
 1.04(0.11)
ab
 0.49(0.06)
c
 <0.001 
Liver (g) 1.09(0.06)
a
 0.80(0.03)
c
 0.98(0.04)
ab
 1.01(0.05)
ab
 0.87(0.02)
bc
 0.77(0.02)
c
 0.79(0.03)
 c
 <0.001 
VSI (%)
2
 7.12(0.20)
bc
 7.03(0.22)
bc
 7.81(0.20)
b
 7.43(0.16)
bc
 8.95(0.23)
a
 7.10(0.19)
bc
 6.92(0.16)
c
 <0.001 
MSI (%)
3
 1.27(0.13)
b
 1.19(0.14)
bc
 0.98(0.12)
bc
 0.99(0.10)
bc
 1.97(0.16)
a
 1.32(0.13)
b
 0.70(0.08)
c
 <0.001 
HSI (%)
4
 1.23(0.04)
bc
 1.05(0.02)
cd
 1.76(0.08)
a
 1.29(0.04)
b
 1.36(0.04)
b
 0.99(0.02)
d
 1.10(0.04)
cd
 <0.001 
SGR (%)
5
 1.97(0.02)
a
 1.82(0.04)
b
 1.38(0.01)
d
 1.77(0.05)
b
 1.57(0.01)
c
 1.77(0.03)
b
 1.67(0.01)
b
 <0.001 
FE (%)
6
  1.07(0.01)
a
 1.08(0.01)
a
 0.95(0.02)
b
 1.10(0.01)
a
 0.88(0.01)
c
 1.09(0.01)
a
 1.08(0.01)
a
 < 0.001 
         
Whole body composition  
(% wet weight) 
       
 
Moisture 67.6(0.21)
b
 68.3(0.07)
b
 69.9(0.31)
a
 69.70(0.07)
a
 66.3(0.08)
c
 68.2(0.27)
b
 70.3(0.34)
a
 <0.001 
Crude protein 17.5(0.16)
a
 16.4(0.29)
ab
 16.5(0.3)
ab
 16.5(0.25)
ab
 15.8(0.08)
b
 17.5(0.17)
ab
 16.9(0.38)
ab
 0.017 
Crude lipid 9.28(0.32)
a
 8.71(0.10)
ab
 8.03(0.13)
ab
 8.25(0.51)
ab
 8.41(0.52)
ab
 9.03(0.24)
b
 6.95(0.08)
b
 0.005 
         
Retention, % intake         
Nitrogen  37.0(0.63)
a
 33.4(0.49)
ab
 31.7(0.46)
bc
 34.5(0.31)
ab
 27.7(0.45)
c
 36.0(0.45)
a
 36.1(1.33)
a
 <0.001 
Lipid 64.3(1.19)
a
 58.8(0.92)
b
 46.9(0.73)
c
 57.4(0.58)
b
 50.1(0.84)
c
 65.6(1.29)
a
 46.6(1.98)
c
 <0.001 
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Table 4. Effect of nutrient deficiencies on basic plasma biochemistry of sea bream fed to visual satiety from May to July (13 weeks). Data are the 801 
mean (SEM) of 10 fish. Different superscript letters in each row indicate significant differences among dietary treatments (SNK test, P<0.05). 802 
1
Result values from one-way analysis of variance. nd, not determined 803 
 804 
 CTRL SAA 
n-3 
LC-PUFA 
PL P Min Vit P-value
1
 
Haemoglobin (g/dL) 7.16(0.47)
ab 
6.62(0.30)
ab 
5.90(0.36)
b 
7.09(0.42)
ab 
7.79(0.47)
a
 7.19(0.34)
ab 
8.13(0.47)
a 
0.008 
Haematocrit (%) 32.8(1.68)
a 
34.1(1.33)
a 
27.4(0.88)
b 
30.5(0.97)
ab 
34.9(1.69)
a 
36.2(1.63)
a 
32.8(1.48)
a 
0.001 
RBC x 10
-6
/mL 2.66(0.07)
a 
2.53(0.09)
a 
2.07(0.05)
b 
2.31(0.13)
b 
2.53(0.11)
ab 
2.80(0.08)
a 
2.79(0.09)
a 
<0.001 
MCF (g/L) 6.62(0.21)
a 
nd 7.37(0.24)
b 
6.90(0.14)
ab 
nd nd nd 0.048 
Glucose (mg/dl) 56.1(2.86) 58.3(2.86) 56.0(2.13) 52.3(1.40) 57.5(3.10) 57.3(1.83) 50.6(1.96) 0.099 
Triglycerides (mM) 0.87(0.09)
a 
0.94(0.10)
a
 0.53(0.05)
b
 0.86(0.09)
a
 2.22(0.26)
c
 0.86(0.06)
a
 0.62(0.08)
ab
 <0.017 
Total cholesterol (mg/dL) 152.2(10.7)
a
 130.5(3.91)
ab
 65.62(7.36)
c 
113.6(5.52)
b 
192.5(9.67)
d 
139.9(9.66)
a 
90.7(5.23)
e 
<0.001 
HDL cholesterol (mg/dL) 119.0(9.38)
a 
123.6(5.68)
a 
64.2(3.76)
b 
110.7(6.39)
ad 
159.7(8.44)
c 
120.1(11.9)
a 
89.9(6.96)
d 
<0.001 
VLDL/LDL cholesterol (mg/dL) 34.1(9.31)
ab 
18.9(1.58)
ab 
16.5(1.39)
a 
22.8(3.33)
ab 
52.2(6.38)
b 
23.2(2.16)
ab 
18.4(2.62)
a 
0.012 
Total proteins (g/L) 33.8(1.81)
a 
28.4(0.66)
b 
24.1(2.05)
b 
26.3(1.37)
b 
38.1(1.85)
a 
35.3(1.86)
a 
26.1(2.23)
b 
<0.001 
ALAT (U/L) 3.21(0.46) 3.15(0.24) 2.29(0.29) 2.83(0.35) 2.78(0.37) 2.56(0.27) 2.36(0.41) 0.362 
ASAT (U/L)  19.5(1.31) 19.9(1.86) 15.1(4.03) 24.1(7.62) 16.5(2.43) 25.6(5.96) 17.1(1.86) 0.507 
GLDH (U/L) 2.25(0.17) 1.95(0.13) 2.02(0.25) 1.63(0.29) 1.43(0.30) 1.59(0.24) 1.18(0.32) 0.078 
ALP (U/L) 78.8(6.34)
a
 80.6(4.12)
a
 79.2(5.41)
a
 60.8(2.41)
b
 101.1(8.52)
c
 92.6(6.33)
c
 76.2(4.65)
ac
 0.002 
Creatinine (mg/dL) 0.12(0.01)
a 
0.10(0.01)
a 
0.06(0.01)
b 
0.10(0.01)
a 
0.12(0.01)
a 
0.10(0.01)
a 
0.05(0.01)
b 
<0.001 
Choline (µM) 15.1(1.30)
a 
10.6(0.6)
bc 
15.5(1.61)
a 
13.2(1.11)
ab 
13.8(0.97)
ab 
10.4(0.77)
bc 
9.00(0.57)
c 
<0.001 
Calcium (mg/dL) 11.2(0.50)
a 
11.2(0.26)
a 
9.78(0.52)
a 
10.4(0.28)
a 
11.8(0.76)
a 
10.9(0.32)
a 
6.64(1.64)
b 
<0.001 
Chloride (mg/dL) 448.6(6.60) 445.0(7.75) 472.6(5.82) 464.9(10.9) 457.4(12.5) 451.2(5.22) 451.2(12.9) 0.370 
Magnesium (mg/mL) 1.82(0.17) 1.81(0.05) 1.67(0.04) 1.71(0.09) 1.75(0.21) 1.89(0.10) 1.78(0.14) 0.923 
Phosphate (mg/dL) 14.7(0.40)
a 
13.1(0.45)
a 
14.01(0.52)
a 
13.7(0.0.45)
a 
7.94(0.25)
b 
12.9(0.32)
a 
14.8(0.55)
b 
<0.001 
Antioxidant capacity (Trolox mM) 0.25(0.03)
a 
0.37(0.03)
b 
0.41(0.03)
b 
0.43(0.03)
b 
0.61(0.03)
c 
0.65(0.06)
c 
0.68(0.03)
c 
<0.001 
Lysozyme (U/L) 97.7(25.98) 14.4(5.01) 70.7(35.90) 98.7(16.56) 51.5(18.30) 35.5(14.37) 68.0(18.40) 0.122 
Respiratory burst (IRLU) 337.0(54.6)a 336.5(37.7)a 1933.5(254.9)b 479.0(104.1)a 332.50(39.2)a 326.0(32.3)a 365.0(37.7)a <0.001 
GH (ng/mL) 5.13(48)
a
 7.35(0.94)
ab
 14.0(0.23)
c
 10.0(2.04)
b
 13.3(2.16)
c
 10.1(1.31)
b
 12.3(0.97)
c
 <0.001 
IGF-I (ng/mL) 96.7(0.85)
a
 78.7(5.15)
b
 45.1(4.34)
c
 69.1(4.68)
b
 53.1(3.88)
c
 66.6(2.61)
b
 64.6(4.61)
b
 <0.001 
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Table 5. Summary of the histological features observed in the liver and anterior (AI) and posterior 
(PI) intestine of fish fed control (CTRL) and nutrient deficient diets. The intensity of the features was 
graded from absence (-) to the highest observed level (+++). 
 
Tissue Trait CTRL SAA n-3 LC-
PUFA 
PL P Min Vit 
Liver Lipid droplets - + ++ +/- + + - 
 Glycogen PAS+ - ++ + - ++ + ++ 
AI Goblet cells PAS+ ++ ++ - - - - + 
 Lipid droplets - - +++ ++ - - ++ 
 Submucosal granulocytes - - - + - + ++ 
 Lymphocytes - - - - - - + 
PI Goblet cells PAS+ + - - + - - + 
 Goblet cells Giemsa+ ++ ++ + ++ - - - 
 Submucosal granulocytes  - - - - - + + 
 Epithelial lymphocytes - - - + - - + 
 Rodlet cells - - - + + ++ + 
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Figure 1 
  
33 
 
Figure 2 
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Figure 3 
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Supplemental Table 1.  Set of clinical signs for the diagnosis of nutrient deficiencies in gilthead sea 
bream fed nutrient deficient diets.*, indicates the magnitude of change.  
 
PARAMETER CATEGORY/ANALYTE DIET
SAA n-3 LC-PUFA PL P Min Vit
Growth performance Growth Decreased Decreased* Decreased Decreased Decreased Decreased
Feed efficiency No change Decreased No change Decreased* No change No change
Feed intake Decreased Decreased* Decreased Decreased Decreased Decreased
Somatic indexes Hepatosomatic index No change Increased No change No change Decreased No change
Mesenteric fat index No change Decreased Decreased Increased No change Decreased*
Viscerosomatic index No change No change No change Increased No change No change
Nutrient retention Fat retention Decreased Decreased* Decreased Decreased No change Decreased*
Nitrogen retention No change Decreased No change Decreased* No change No change
Haematology Hematocrit No change Decreased No change No change No change No change
Hemoglobin No change Decreased No change No change No change No change
Red Blood Cells No change Decreased No change No change No change No change
Blood biochem/electrolytes Calcium No change No change No change No change No change Decreased
Chloride No change No change No change No change No change No change
Magnesium No change No change No change No change No change No change
Phosphate No change No change No change Decreased No change No change
Blood biochem/metabolites Glucose No change No change No change No change No change No change
Triglycerides No change Decreased No change Increased No change Decreased
Total cholesterol No change Decreased* No change Increased No change Decreased
Total proteins Decreased Decreased Decreased No change No change Decreased
Creatinine No change Decreased No change No change No change Decreased
Choline Decreased No change No change No change Decreased Decreased*
Blood biochem/enzymes ALAT No change No change No change No change No change No change
ASAT No change No change No change No change No change No change
GLDH No change No change No change No change No change No change
ALP No change No change Decreased Increased Decreased Decreased
Blood biochem/ Antioxidant capacity Increased Increased Increased Increased* Increased* Increased*
oxidative/inflammatory condition Respiratory burst No change Increased No change No change No change No change
Lysozyme No change No change No change No change No change No change
Blood biochem/hormones Growth Hormone Increased Increased Increased* Increased Increased Increased
IGF-I Decreased Decreased Decreased* Decreased Decreased Decreased
Histology/liver Glycogen depots Increased Increased No change Increased Increased No change
Lipid droplets Increased Increased* No change Increased Increased No change
Histology/ant. intestine Lipid droplets No change Increased* Increased No change No change Increased
Lymphocyte submucosa No change No change No change No change No change Increased
Granulocyte submucosa No change No change Increased No change Increased Increased*
GC PAS + No change Decreased Decreased Decreased Decreased Decreased
Histology/post. intestine Lipid droplets No change No change No change No change No change No change
Lymphocyte submucosa No change No change Increased No change No change Increased
Granulocyte submucosa No change No change No change No change Increased Increased
GC PAS + No change No change Increased No change No change Increased
GC Giemsa + No change Decreased No change Decreased Decreased Decreased
Rodlet cells No change No change Increased Increased Increased* Increased
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Supplemental  Table 2. Reference values for organosomatic indexes and basic blood biochemistry in farmed gilthead sea bream.  
 
ORGANOSOMATIC 
INDEXES 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Hepatosomatic index (HSI) 
Summer Fast growth 1.5 1 2 % 
HSI is lowered by deficiencies in 
minerals and vitamins. Liver fat 
deposition and HSI are increased by 
deficiencies in EFA, and liver 
steatosis is exacerbated in winter. 
Late autumn Slow growth 2.1 1.6 3 % 
Mesenteric index (MSI) 
  
Summer Fast growth 1.7 1 2.5 % MSI is increased by P deficiencies. 
MSI is lowered by deficiencies in 
SAA, EFA, PL and vitamins. Late autumn Slow growth 1.2 0.7 2 % 
      
 
        
HAEMATOLOGY 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Haemoglobin (Hb) 
Summer Fast growth 5.7 4 8 g/dl 
Hb concentration is decreased by 
EFA deficiencies and low FM diets. 
High Hb concentrations > 12 g/dl are 
found in hypoxic conditions (oxygen 
saturation < 20%). 
Late autumn Slow growth 6.5 5 9 g/dl 
Haematocrit (Hct) 
Summer Fast growth 35.5 25 45 % Low Hc values are found in fish with 
clinical signs of EFA deficiencies. Hc 
values > 50% are found in hypoxic 
conditions (oxygen saturation < 
20%).  
Late autumn Slow growth 32.5 20 40 % 
Red blood cells (RBC) 
Summer Fast growth 2.4 2 3 10-6/ml 
RBC counts (< 2 million/ml) are low 
in fish with clinical signs of EFA 
deficiencies. This is a type of 
haemolytic anaemia with an 
enhanced erythroid osmotic fragility 
Late autumn Slow growth 2.9 2.5 3.5 10-6/ml 
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(MCF>7 g/l). 
 
ELECTROLYTES 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Chloride (Cl) 
Summer/late 
autumn 
Fast/slow 
growth 
450 350 500 mg/dl 
Poorly regulated at the nutritional 
level. 
Calcium (Ca) 
Summer Fast growth 13.4 12 16 mg/dl Hypocalcaemia (< 7 mg/dl) is found 
in fish with clinical signs of vitamin 
deficiencies. 
Late autumn Slow growth 
12.5 
10 14 
mg/dl 
Phosphate (HPO4
2−) 
Summer/late 
autumn 
Fast/slow 
growth 
11.4 9.5 14 mg/dl 
Low phosphate concentrations (< 9 
mg/dl) are found in fish with clinical 
signs of P deficiencies. 
Magnesium (Mg) 
Summer/late 
autumn 
Fast/slow 
growth 
1.9 1.5 2.2 mg/ml 
Poorly regulated at the nutritional 
level. 
      
 
        
METABOLITES 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Glucose 
Summer/late 
autumn 
Fast/slow 
growth 
52.6 45 90 mg/dl 
Basal glucose levels are poorly 
influenced by fish size. Consistent 
hyperglycaemia (> 125 mg/dl) is 
found in hypoxic conditions and 
crowding stress. 
Lactate 
Spring/early 
summer 
Fast growth 9 8 11 mg/dl 
High plasma lactate concentrations 
(> 12 mg/dl) are found in hypoxic 
steady states. 
Triglycerides 
Summer Fast growth 0.59 0.5 1 mM Summer hypertriglyceridemia (> 1.5 
mM) is found in fish with clinical 
signs of P deficiencies. Late autumn Slow growth 2.7 0.7 4 mM 
Total cholesterol Summer Fast growth 140 100 200 mg/dl 
Summer hypocholesterolemia (< 100 
mg/dl) is found in fish with clinical 
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Late autumn Slow growth 210 150 300 mg/dl 
signs of deficiencies in EFA, PL and 
vitamins. Summer 
hypercholesterolemia (> 170 mg/dl) 
is found in fish with clinical signs of P 
deficiencies. 
METABOLITES 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Proteins 
Summer Fast growth 41 35 45 mg/dl Summer hypoproteinemia (< 30 
mg/ml) is found in fish with clinical 
signs of deficiencies in SAA, EFA, PLs 
and vitamins. 
Late autumn Slow growth 50 45 55 mg/dl 
Creatinine 
Summer Fast growth 0.12 0.08 0.15 mg/dl Reduced creatinine levels (< 0.07 
mg/dl) are found in summer growing 
fish with clinical signs of deficiencies 
in vitamins and EFA. 
Late autumn Slow growth 0.20 0.1 0.3 mg/dl 
Choline 
Summer Fast growth 16 11.5 22 µM Reduced choline levels (< 10.5 
ng/ml) are found in summer growing 
fish with clinical signs of deficiencies 
in SAA, minerals and vitamins. 
Late autumn Slow growth 7.2 5 10 µM 
  
    
 
      
  
ENZYMES 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Alanine aminotransferase 
(ALAT)  
Summer/late 
autumn 
Fast/slow 
growth 
1.4 0.5 3 U/l 
No clinical histopathological signs 
are found with this range of 
variation. 
Aspartate 
aminotransferase (ASAT) 
Summer/late 
autumn 
Fast/slow 
growth 
15 5 40 U/l 
No clinical histopathological signs 
are found with this range of 
variation. 
Glutamate dehydrogenase 
(GLDH) 
Summer/late 
autumn 
Fast/slow 
growth 
0.7 0.2 1.5 U/l 
No clinical histopathological signs 
are found with this range of 
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variation. 
Alkaline phosphatase 
(ALP) 
Summer Fast growth 98 75 125 U/l 
Plasma ALP activity is increased by P 
deficiencies. Low ALP activities are 
found in summer growing fish with 
clinical signs of PL and vitamin 
deficiencies (< 70 U/l) 
Late autumn Slow growth 85 55 100 U/l 
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INFLAMATORY & 
ANTIOXIDANT STATUS 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Lysozyme 
Summer Fast growth 150 50 300 U/l Reduced levels in fish with clinical 
signs of deficiencies in SAA. Late autumn Slow growth 55 20 100 U/l 
Respiratory burst  
Summer Fast growth 500 300 600 IRLU Marked increases (more than 4-5 
fold) in fish with deficiencies in EFA. Late autumn Slow growth 4000 500 10000 IRLU 
Total antioxidant capacity 
(TAC, Trolox mM) 
Summer Fast growth 0.9 0.5 1 
Trolox 
(mM) 
TAC is highly influenced by the 
environment and nutritional 
condition, and positively correlates 
for a given physiological conditions 
with the risk of oxidative stress.  
Increased values for TAC are 
reported in fish with clinical signs of 
deficiencies in vitamins, minerals 
and P. Increased TAC is also reported 
in hypoxia. 
Late autumn Slow growth 1.1 0.8 1.25 
Trolox 
(mM) 
      
 
      
  
HORMONES 
Environmental 
condition 
Fish condition Mean Lower limit Upper limit Unit Comments 
Growth hormone (GH) 
Summer Fast growth 7.5 3 10 ng/ml 
Circulating levels of GH are 
nutritionally and seasonality 
regulated. Malnutrition induces a 
state of GH resistance and marked 
increases in circulating GH 
concentrations (> 10 ng/ml) are 
found in fish with clinical signs of 
specific nutrient deficiencies and 
growth impairment. 
Late autumn Slow growth 2.5 1.5 3 ng/ml 
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Insulin-like growth factor-I 
(IGF-I) 
Summer Fast growth 85 50 110 ng/ml 
Low IGF-I concentrations in 
combination with high GH 
concentrations are strong markers of 
malnutrition and impaired growth. 
 
